Terms: = Kidney tumors AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
25 results:
1. Medicare Accountable Care Organizations: Post-acute Care Use and Post-surgical Outcomes in Urologic Cancer Surgery.
Katragadda C; Fung C; Yousefi-Nooraie R; Cupertino P; Joseph J; Kim Y; Li Y
Urology; 2022 Sep; 167():102-108. PubMed ID: 35772480
[TBL] [Abstract] [Full Text] [Related]
2. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of Cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
3. Intermediate- and long-term oncological outcomes of active surveillance for localized renal masses: a systematic review and quantitative analysis.
Klatte T; Berni A; Serni S; Campi R
BJU Int; 2021 Aug; 128(2):131-143. PubMed ID: 34060192
[TBL] [Abstract] [Full Text] [Related]
4. A pan-cancer analysis of the HER family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Yang X; Miao Y; Wang J; Mi D
Life Sci; 2021 May; 273():119307. PubMed ID: 33691171
[TBL] [Abstract] [Full Text] [Related]
5. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract] [Full Text] [Related]
6. The Utility of erbb4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
7. Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
O'Connor JM; Fessele KL; Steiner J; Seidl-Rathkopf K; Carson KR; Nussbaum NC; Yin ES; Adelson KB; Presley CJ; Chiang AC; Ross JS; Abernethy AP; Gross CP
JAMA Oncol; 2018 Aug; 4(8):e180798. PubMed ID: 29800974
[TBL] [Abstract] [Full Text] [Related]
8. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract] [Full Text] [Related]
9. Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.
Wu F; Wu S; Gou X
Neoplasma; 2018; 65(2):242-252. PubMed ID: 29534586
[TBL] [Abstract] [Full Text] [Related]
10. Next-Generation Sequencing to Detect Deletion of RB1 and erbb4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
Abufaraj M; Moschini M; Soria F; Gust K; Özsoy M; Mathieu R; Rouprêt M; Margulis V; Karam JA; Wood CG; Briganti A; Bensalah K; Haitel A; Shariat SF
World J Urol; 2017 Jul; 35(7):1073-1080. PubMed ID: 27830374
[TBL] [Abstract] [Full Text] [Related]
12. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G
Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Pharmacokinetics and Pharmacodynamics of Afatinib.
Wind S; Schnell D; Ebner T; Freiwald M; Stopfer P
Clin Pharmacokinet; 2017 Mar; 56(3):235-250. PubMed ID: 27470518
[TBL] [Abstract] [Full Text] [Related]
14. Neuregulin-1 Administration Protocols Sufficient for Stimulating Cardiac Regeneration in Young Mice Do Not Induce Somatic, Organ, or Neoplastic Growth.
Ganapathy B; Nandhagopal N; Polizzotti BD; Bennett D; Asan A; Wu Y; Kühn B
PLoS One; 2016; 11(5):e0155456. PubMed ID: 27175488
[TBL] [Abstract] [Full Text] [Related]
15. Isolation and characterization of renal cancer stem cells from patient-derived xenografts.
Hasmim M; Bruno S; Azzi S; Gallerne C; Michel JG; Chiabotto G; Lecoz V; Romei C; Spaggiari GM; Pezzolo A; Pistoia V; Angevin E; Gad S; Ferlicot S; Messai Y; Kieda C; Clay D; Sabatini F; Escudier B; Camussi G; Eid P; Azzarone B; Chouaib S
Oncotarget; 2016 Mar; 7(13):15507-24. PubMed ID: 26551931
[TBL] [Abstract] [Full Text] [Related]
16. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
[TBL] [Abstract] [Full Text] [Related]
17. Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.
Thomasson M; Hedman H; Ljungberg B; Henriksson R
BMC Res Notes; 2012 May; 5():216. PubMed ID: 22554477
[TBL] [Abstract] [Full Text] [Related]
18. Tyrosine kinase expression profile in clear cell renal cell carcinoma.
Behbahani TE; Thierse C; Baumann C; Holl D; Bastian PJ; von Ruecker A; Müller SC; Ellinger J; Hauser S
World J Urol; 2012 Aug; 30(4):559-65. PubMed ID: 21969129
[TBL] [Abstract] [Full Text] [Related]
19. Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.
Zhou L; Chen J; Li Z; Li X; Hu X; Huang Y; Zhao X; Liang C; Wang Y; Sun L; Shi M; Xu X; Shen F; Chen M; Han Z; Peng Z; Zhai Q; Chen J; Zhang Z; Yang R; Ye J; Guan Z; Yang H; Gui Y; Wang J; Cai Z; Zhang X
PLoS One; 2010 Dec; 5(12):e15224. PubMed ID: 21253009
[TBL] [Abstract] [Full Text] [Related]
20. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.
Liu H; Brannon AR; Reddy AR; Alexe G; Seiler MW; Arreola A; Oza JH; Yao M; Juan D; Liou LS; Ganesan S; Levine AJ; Rathmell WK; Bhanot GV
BMC Syst Biol; 2010 Apr; 4():51. PubMed ID: 20420713
[TBL] [Abstract] [Full Text] [Related]
[Next]
